Retatrutide Side Effects: What Studies and Users Report
What FDA labels, clinical studies and people who use Retatrutide report, how strong that evidence is, and what is still unknown.
Side effects reported in studies
Side effects reported in published studies, strongest design first. Frequencies are quoted as the source gives them; animal results are labelled.
| Side effect | How common | Study type | Source |
|---|---|---|---|
| Gastrointestinal events | most common | Human RCTn = 2339 | The New England journal of medicine 2026, PMID 42814954 |
| Diarrhoea | 96 [34%] of 286 on 12 mg vs 38 [13%] of 287 on placebo | Human RCTn = 1152 | Lancet 2026, PMID 42810372 |
| Nausea | 40 [14%], 59 [21%], 80 [28%] (4, 9, 12 mg) vs 23 [8%] placebo | Human RCTn = 1152 | Lancet 2026, PMID 42810372 |
| Discontinuation due to adverse events or death | 9 mg 33 [12%], 12 mg 22 [8%], 4 mg 11 [4%], placebo 14 [5%] | Human RCTn = 1152 | Lancet 2026, PMID 42810372 |
| Gastrointestinal events | most common; dose-related | Human RCTn = 338 | The New England journal of medicine 2023, PMID 37366315 |
| Heart rate increase | dose-dependent, peaked at 24 weeks | Human RCTn = 338 | The New England journal of medicine 2023, PMID 37366315 |
| Gastrointestinal events | 67 (35%) of 190 on retatrutide vs 6 (13%) of 45 on placebo | Human RCTn = 281 | Lancet 2023, PMID 37385280 |
| Severe hypoglycaemia“There were no reports of severe hypoglycaemia and no deaths during the study.” | Frequency not stated | Human RCTn = 281 | Lancet 2023, PMID 37385280 |
| Overall adverse-event risk | highest risk of the compared drugs | Meta-analysisn = 29506 | Obesity 2025, PMID 40685589 |
Stomach and gut side effects rose with dose, were mostly mild to moderate, and were partly reduced by a 2 mg rather than 4 mg starting dose.
- Nausea
- Decreased appetite
- Diarrhea
- Vomiting
- Constipation
- Raised heart rate at higher doses
Source: phase 2 trial (New England Journal of Medicine, 2023). Rates by dose are pending review.
Overall safety findings
What studies said about safety as a whole, without naming a specific effect.
| Finding | How common | Study type | Source |
|---|---|---|---|
| Discontinuation due to adverse events | 2-5% with retatrutide vs 0% with placebo | Human RCTn = 537 | Lancet 2026, PMID 42250575 |
| Serious adverse events“Adverse events were similar between groups.” | Frequency not stated | Human RCTn = 189 | The lancet. Diabetes & endocrinology 2025, PMID 40609566 |
| Treatment-emergent adverse events | 33 (63%) on LY3437943 vs 8 (54%) on placebo | Human RCTn = 72 | Lancet 2022, PMID 36354040 |
What users report
Side effects people describe from their own use of Retatrutide, quoted from 30 Reddit threads we read in r/PEDs, r/Peptides, r/Retatrutide and r/moreplatesmoredates (searched 11 Oct 2026). Each count is the number of different people in those threads, not how common the effect is. These reports are unverified: products bought outside a pharmacy are often mislabelled or impure, and many people take several compounds at once.
| What people noticed | People reporting it | In their words |
|---|---|---|
| Tiredness or lethargy | 85 | “I get so tired the day after injections it's almost not worth it.” r/Retatrutide, Sep 2026“More tired to be honest because of the Reta and lowered calories” r/moreplatesmoredates, Mar 2026Also taking other compounds |
| Skin sensitivity or burning sensation | 80 | “Every piece of my skin would feel hypersensitive and just this side of painful for a couple days.” r/Retatrutide, Sep 2026“had same experience but about a month and half in it subsided as well as the skin sensitivity” r/Retatrutide, Mar 2026 |
| Trouble sleeping | 70 | “I was waking up every night at 3am and then struggling to fall back asleep for an hour.” r/Retatrutide, Sep 2026“230 on the dot and it takes me like an hour and a half to go back to sleep” r/Retatrutide, Sep 2026 |
| Racing heart or raised resting heart rate | 59 | “I was having heart palpitations, numbness in the arms, and my resting was hanging around 100bpm” r/Retatrutide, Nov 2025“I really disliked the increased heart rate (and it was only 8bpm) and the nuking of my HRV.” r/Peptides, Mar 2026 |
| Anhedonia or flat mood | 35 | “the anhedonia effect started to come on more noticeably around 5-6mg” r/Retatrutide, Jul 2026“the anhedonia is definitely having an impact on my shopping habits” r/Retatrutide, Oct 2026 |
| Nausea or vomiting | 34 | “I felt nothing but constant nausea and stomach aches to the point where I couldn’t work.” r/Retatrutide, Sep 2026“I started vomiting nonstop (couldn’t even keep water down) for about 2 weeks straight” r/Retatrutide, Oct 2026 |
| Anxiety or jitteriness | 29 | “anxiety, low energy but unable to sleep, felt like I was crawling out of my skin” r/Retatrutide, Jun 2026“noticed I was experiencing a bit of anxiety on it mildly, little bit of nausea” r/Retatrutide, Aug 2025 |
| Diarrhea | 29 | “Would get diarrhea within a couple of hours after eating the salad.” r/Retatrutide, Feb 2025“Diarrhea. Really, really bad, completely liquid diarrhea.” r/Retatrutide, Dec 2025 |
| Acid reflux or sulfur burps | 26 | “I definitely have to keep taking my antacids daily, otherwise I have horrendous reflux and indigestion” r/Retatrutide, Oct 2026“I will say one side I did get a few hours after each reta injection is like this feeling of extreme acid reflux.” r/PEDs, Feb 2025 |
| Low libido | 22 | “the higher the dose the less libido and it comes back for sure” r/Retatrutide, Oct 2026“I’m on 2.5 mg and the libido side effects are back.” r/Retatrutide, Sep 2026 |
| Joint or muscle aches | 17 | “the damage it does to my joints, dries them out and makes them more fragile to hard training” r/Peptides, Mar 2026“my bones are cracking in my knees, and they feel like the joints are just gonna split apart” r/Retatrutide, Sep 2025 |
| Injection-site redness, itching or welts | 16 | “When I increased my dose to 2mg that’s when this started for me. It’s so itchy and annoying.” r/Retatrutide, May 2026“I get really red and itchy for a few days around where I inject but it heals pretty quickly.” r/Retatrutide, May 2026 |
| Feeling cold or chills | 13 | “Main side effect, cold all the time.” r/Retatrutide, Nov 2024Also taking other compounds“I even have chills around 2 or 3AM.” r/Retatrutide, Sep 2026 |
| Low mood | 11 | “Shitty mood and and just want to lash out.” r/Retatrutide, Jul 2026“I had to reduce my dose because I was crying nonstop three days a week.” r/Retatrutide, Jul 2026 |
| Hair shedding or thinning | 10 | “I came off Reta for a reset and started taking marine collagen and the shedding has finally abated.” r/Retatrutide, Jan 2026“noticed my hair has thinned so much for the past two weeks” r/Retatrutide, Feb 2026 |
| Dizziness | 10 | “dizziness, eye floaters and flashes of light” r/Retatrutide, Nov 2025“I also get very lightheaded and dizzy on it” r/Retatrutide, Nov 2025 |
| Stomach pain or cramps | 10 | “had stomach burns and if I ate something it was worse” r/Retatrutide, Aug 2025“Serious pains in my right side when taking Reta.” r/Retatrutide, Aug 2026 |
| Constipation | 9 | “I have only had constipation, bloating, and a lot of gas” r/Retatrutide, Sep 2026“a little constipation if I don’t get enough fiber” r/Retatrutide, Sep 2026 |
| Headache or migraine | 8 | “At week 4 on Reta I started getting horrible headaches lasting all day for like a straight week.” r/Retatrutide, Jul 2026“The headaches this week have been excruciating.” r/Retatrutide, Jul 2026 |
| Gas or burping | 7 | “I can’t stop burping and farting, it’s literally non stop all day and night” r/Retatrutide, Dec 2025“the burping is driving me nuts too” r/Retatrutide, Dec 2025 |
| Frequent urination | 6 | “The more than frequent urination alone?” r/Retatrutide, Sep 2025“Excess urination” r/Retatrutide, Sep 2026 |
| Vivid dreams | 5 | “I get that, very vivid and quite odd also I can remember them much more clearly.” r/Retatrutide, Sep 2026“I’ve been having strange but very vivid dreams that I can actually remember.” r/Retatrutide, Oct 2026 |
| Dry mouth | 5 | “Extremely dry mouth- to the point my cheecks will stick to my teeth and gums.” r/Retatrutide, Oct 2026“a bit of dry mouth in the middle of the night” r/Retatrutide, Sep 2026 |
| Tingling, burning or numbness in hands or feet | 5 | “The tingles in my hands and random cramps in my arms and legs.” r/Retatrutide, Sep 2026“I have burning tingling sensation in my feet.” r/Retatrutide, Sep 2026 |
| Hearing changes or muffled ears | 5 | “I feel like I have extra fluid into my ears…when I talk, I hear myself echo.” r/Retatrutide, Oct 2026“the weird ear canal thing where my ears feel plugged if I’m dehydrated” r/Retatrutide, Oct 2026 |
Showing the 25 most reported of 59 different effects people described.
5 people in the same threads said they noticed no side effects:
A symptom others mention is not proof that it is harmless. If you have anything on the urgent list below, get care whatever others report.
What is not known
- How common each effect is at the doses people use outside of studies.
- Effects that take longer to appear than the length of the published studies.
- How Retatrutide interacts with other medicines and supplements.
- Whether research-grade products, which are not checked by the FDA, behave like the material used in studies.
When to get medical help
This is not a complete list. A doctor or pharmacist can help you judge whether a symptom is related.
Retatrutide side effects in clinical trials, by dose
The phase 2 obesity trial states that retatrutide's dose-response relationships for side effects, safety and efficacy were not known.[1]
In that phase 2 trial, gastrointestinal events were the most common adverse events, were dose-related, and were partially mitigated with a lower starting dose (2 mg vs. 4 mg).[1]
Dose-dependent increases in heart rate peaked at 24 weeks and declined afterwards.[1]
Retatrutide nausea, diarrhoea, vomiting and constipation by arm in the phase 2 trial
The registry results name seven groups: EG000 is placebo, EG001 is 1 mg, EG002 is 4 mg after a 2 mg start, EG003 is 4 mg given without a step, EG004 is 8 mg after a 2 mg start, EG005 is 8 mg after a 4 mg start, and EG006 is 12 mg after a 2 mg start.[2]
Nausea in the phase 2 obesity trial's posted results, participants affected of those at risk: EG000 8 of 70; EG001 10 of 69; EG002 6 of 33; EG003 12 of 33; EG004 6 of 35; EG005 21 of 35; EG006 28 of 62.[2]
Diarrhoea in the phase 2 obesity trial's posted results, participants affected of those at risk: EG000 8 of 70; EG001 6 of 69; EG002 4 of 33; EG003 4 of 33; EG004 7 of 35; EG005 7 of 35; EG006 9 of 62.[2]
Vomiting in the phase 2 obesity trial's posted results, participants affected of those at risk: EG000 1 of 70; EG001 2 of 69; EG002 4 of 33; EG003 4 of 33; EG004 2 of 35; EG005 9 of 35; EG006 12 of 62.[2]
Constipation in the phase 2 obesity trial's posted results, participants affected of those at risk: EG000 2 of 70; EG001 5 of 69; EG002 5 of 33; EG003 2 of 33; EG004 4 of 35; EG005 4 of 35; EG006 10 of 62.[2]
TRIUMPH-2: gastrointestinal events and stops by dose
In adults with obesity and type 2 diabetes, diarrhoea occurred in 27%, 34% and 34% at 4, 9 and 12 mg, against 13% on placebo.[4]
Nausea occurred in 14%, 21% and 28% of participants across the retatrutide groups, against 8% on placebo.[4]
Permanent stops for adverse events or death were most frequent at 9 mg (12%), then 12 mg (8%), against 4% at 4 mg and 5% on placebo.[4]
Excess over placebo in percentage points. Diarrhoea: 14 (4 mg), 21 (9 mg), 21 (12 mg). Nausea: 6, 13 and 20. Stops: -1, 7 and 3.
Calculated from diarrhoea 27, 34, 34; diarrhoea placebo 13; nausea 14, 21, 28; nausea placebo 8; stops 4, 12, 8; stops placebo 5. Formula: retatrutide % minus placebo % at 4/9/12 mg
Other trial signals
In a monotherapy trial in type 2 diabetes, stops for adverse events were 2-5% with retatrutide and 0% with placebo.[7]
A pooled analysis of earlier trials reported more non-severe gastrointestinal and hypersensitivity adverse events than placebo.[29]
A network meta-analysis of weight-loss drugs found that retatrutide had the highest adverse-event risk.[6]
Common questions
What are the side effects of Retatrutide?
In the phase 2 trial the most common were nausea, decreased appetite, diarrhea. Stomach and gut side effects rose with dose, were mostly mild to moderate, and were partly reduced by a 2 mg rather than 4 mg starting dose. Higher doses also raised heart rate.
What side effects do people who use Retatrutide report?
In the 30 Reddit threads we read (11 Oct 2026), people most often described tiredness or lethargy (85 people), skin sensitivity or burning sensation (80 people), trouble sleeping (70 people). These are unverified personal reports, often from products of unknown purity, and the counts are not rates.
Is Retatrutide safe?
Its safety has not been established by an FDA review. Retatrutide is investigational and not approved for any use. Research-chemical products are not checked for purity or dose.
Is Retatrutide banned in sport?
Yes. Prohibited by WADA (S0). Tested athletes should not use it.
Is GLP-3 safe?
The trials report gastrointestinal events as the most common adverse events.[3]
What are the long-term side effects of GLP-3?
A pooled analysis of earlier trials says phase 3 trials are expected to shed further light on long-term efficacy and safety.[29]
How much did retatrutide raise heart rate in the phase 2 trial?
The phase 2 obesity abstract says heart-rate rises grew with dose, were highest at 24 weeks and then fell back. It gives no beats-per-minute figure.[1]
More on Retatrutide
Sources
- 1Triple-Hormone-Receptor Agonist Retatrutide for Obesity: A Phase 2 Trial (Jastreboff AM et al.)New England Journal of Medicine · 2023PMID 37366315Accessed 2 Oct 2026
- 2A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities (NCT04881760; arms and posted results)ClinicalTrials.gov (U.S. National Library of Medicine) · 2021clinicaltrials.govAccessed 2 Oct 2026
- 3Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity (TRIUMPH-1; Jastreboff AM et al.)New England Journal of Medicine · 2026PMID 42814954Accessed 2 Oct 2026
- 4Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.Lancet (London, England) · 2026PMID 42810372Accessed 2 Oct 2026
- 5Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA.Lancet (London, England) · 2023PMID 37385280Accessed 2 Oct 2026
- 6Efficacy and Safety of GLP-1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMA.Obesity (Silver Spring, Md.) · 2025PMID 40685589Accessed 2 Oct 2026
- 7Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial.Lancet (London, England) · 2026PMID 42250575Accessed 2 Oct 2026
- 8Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial.The lancet. Diabetes & endocrinology · 2025PMID 40609566Accessed 2 Oct 2026
- 9LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial.Lancet (London, England) · 2022PMID 36354040Accessed 2 Oct 2026
- 10Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 11Reddit thread in r/moreplatesmoredates (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 12Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 13Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 14Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
- 15Reddit thread in r/Peptides (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 16Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 17Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 18Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
- 19Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
- 20Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
- 21Reddit thread in r/PEDs (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
- 22Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
- 23Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 24Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2024reddit.comAccessed 11 Oct 2026
- 25Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 26Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2025reddit.comAccessed 11 Oct 2026
- 27Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 28Reddit thread in r/Retatrutide (user reports, unverified)Reddit, via the Arctic Shift archive · 2026reddit.comAccessed 11 Oct 2026
- 29Effects of once-weekly subcutaneous retatrutide on weight and metabolic markers: A systematic review and meta-analysis of randomized controlled trials.Metabolism open · 2024PMID 39318607Accessed 2 Oct 2026
Found an error? Report a correction.